Novo Nordisk
-
Novo Nordisk boosts Wegovy shipments to cope with price pressure from competition from Eli Lilly
Reprinted from: Golden Ten Data Novo Nordisk (NVO.N) is increasing its first dose in the United States of its weight loss drug Wegovy as the company grapples with supply constraints and competition from Eli Lilly (LLY.N)